These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 31228435

  • 21. Preventive use of nitisinone in alkaptonuria.
    Wolffenbuttel BHR, Heiner-Fokkema MR, van Spronsen FJ.
    Orphanet J Rare Dis; 2021 Aug 03; 16(1):343. PubMed ID: 34344451
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of low dose nitisinone in the management of alkaptonuria.
    Sloboda N, Wiedemann A, Merten M, Alqahtani A, Jeannesson E, Blum A, Henn-Ménétré S, Guéant JL, Renard E, Feillet F.
    Mol Genet Metab; 2019 Jul 03; 127(3):184-190. PubMed ID: 31235217
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Patient-reported outcomes and functional assessments of patients with Alkaptonuria in a 3-year Nitisinone treatment trial.
    Spears KR, Rossignol F, Perry MB, Kayser MA, Suwannarat P, O'Brien KE, Bryant JC, Greenwood WF, Fuller S, Gahl WA, Introne WJ.
    Mol Genet Metab; 2024 Jul 03; 143(1-2):108562. PubMed ID: 39121793
    [Abstract] [Full Text] [Related]

  • 26. Perturbations of tyrosine metabolism promote the indolepyruvate pathway via tryptophan in host and microbiome.
    Gertsman I, Gangoiti JA, Nyhan WL, Barshop BA.
    Mol Genet Metab; 2015 Mar 03; 114(3):431-7. PubMed ID: 25680927
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Serum markers in alkaptonuria: simultaneous analysis of homogentisic acid, tyrosine and nitisinone by liquid chromatography tandem mass spectrometry.
    Hughes AT, Milan AM, Davison AS, Christensen P, Ross G, Gallagher JA, Dutton JJ, Ranganath LR.
    Ann Clin Biochem; 2015 Sep 03; 52(Pt 5):597-605. PubMed ID: 25628464
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Alkaptonuria.
    Lorenzini S, Mannoni A, Selvi E.
    N Engl J Med; 2003 Apr 03; 348(14):1408; author reply 1408. PubMed ID: 12672874
    [No Abstract] [Full Text] [Related]

  • 31. Anthropometric, Body Composition, and Nutritional Indicators with and without Nutritional Intervention during Nitisinone Therapy in Alkaptonuria.
    Ranganath LR, Khedr M, Milan AM, Davison AS, Hughes AT, Norman BP, Bygott H, Luangrath E, Judd S, Soulsby C, Olsson B, Imrich R.
    Nutrients; 2024 Aug 15; 16(16):. PubMed ID: 39203858
    [Abstract] [Full Text] [Related]

  • 32. NTBC and alkaptonuria.
    Anikster Y, Nyhan WL, Gahl WA.
    Am J Hum Genet; 1998 Sep 15; 63(3):920-1. PubMed ID: 9718357
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Natural history of alkaptonuria revisited: analyses based on scoring systems.
    Ranganath LR, Cox TF.
    J Inherit Metab Dis; 2011 Dec 15; 34(6):1141-51. PubMed ID: 21748407
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy.
    Zaib S, Rana N, Hussain N, Ogaly HA, Dera AA, Khan I.
    Molecules; 2023 Mar 14; 28(6):. PubMed ID: 36985595
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione.
    Mitchell GA.
    Hum Exp Toxicol; 1996 Feb 14; 15(2):179-81. PubMed ID: 8645506
    [No Abstract] [Full Text] [Related]

  • 40. Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione.
    Ellis MK, Whitfield AC, Gowans LA, Auton TR, Provan WM, Lock EA, Smith LL.
    Toxicol Appl Pharmacol; 1995 Jul 14; 133(1):12-9. PubMed ID: 7597701
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.